Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Stritzker

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Plos One|October 11, 2011
Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coliPhilip J Hill, Jochen Stritzker, Miriam Scadeng, et al.
BMC Microbiology|July 13, 2011
Specific antibody-receptor interactions trigger InlAB-independent uptake of Listeria monocytogenes into tumor cell linesMartin Heisig, Alexa Frentzen, Birgit Bergmann, et al.
Journal of Biomedicine & Biotechnology|April 10, 2010
Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68Ivaylo Gentschev, Ulrike Donat, Elisabeth Hofmann, et al.
Molecular Medicine (Cambridge, Mass.)|March 17, 2009
A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imagingNanhai Chen, Qian Zhang, Yong A Yu, et al.
International Journal of Medical Microbiology : IJMM|June 16, 2010
Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motilityJochen Stritzker, Stephanie Weibel, Carolin Seubert, et al.
International Journal of Cancer|June 5, 2013
Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endotheliumLisa Buckel, Sunil J Advani, Alexa Frentzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2008
Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imagingPeter Brader, Jochen Stritzker, Christopher C Riedl, et al.
Cancer Immunology, Immunotherapy : CII|June 13, 2023
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agentsClaire Battin, Annika De Sousa Linhares, Judith Leitner, et al.
Theranostics|July 23, 2015
Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer AgentLorenz Kirscher, Xosé Luis Deán-Ben, Miriam Scadeng, et al.
Journal of Oncology|July 16, 2010
Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68Ivaylo Gentschev, Klaas Ehrig, Ulrike Donat, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Plos One|October 11, 2011
Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coliPhilip J Hill, Jochen Stritzker, Miriam Scadeng, et al.
BMC Microbiology|July 13, 2011
Specific antibody-receptor interactions trigger InlAB-independent uptake of Listeria monocytogenes into tumor cell linesMartin Heisig, Alexa Frentzen, Birgit Bergmann, et al.
Journal of Biomedicine & Biotechnology|April 10, 2010
Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68Ivaylo Gentschev, Ulrike Donat, Elisabeth Hofmann, et al.
Molecular Medicine (Cambridge, Mass.)|March 17, 2009
A novel recombinant vaccinia virus expressing the human norepinephrine transporter retains oncolytic potential and facilitates deep-tissue imagingNanhai Chen, Qian Zhang, Yong A Yu, et al.
International Journal of Medical Microbiology : IJMM|June 16, 2010
Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motilityJochen Stritzker, Stephanie Weibel, Carolin Seubert, et al.
International Journal of Cancer|June 5, 2013
Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endotheliumLisa Buckel, Sunil J Advani, Alexa Frentzen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2008
Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imagingPeter Brader, Jochen Stritzker, Christopher C Riedl, et al.
Cancer Immunology, Immunotherapy : CII|June 13, 2023
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agentsClaire Battin, Annika De Sousa Linhares, Judith Leitner, et al.
Theranostics|July 23, 2015
Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer AgentLorenz Kirscher, Xosé Luis Deán-Ben, Miriam Scadeng, et al.
Journal of Oncology|July 16, 2010
Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68Ivaylo Gentschev, Klaas Ehrig, Ulrike Donat, et al.
Pageof 4